1
Article 1
Article (1) Definitions For the purpose of applying the provisions of this Law, the following words and expressions shall have the meanings assigned to each of them unless the context otherwise requires: State : The United Arab Emirates. Establishment : The Emirates Drug Establishment. Chairman : The Chairman of the Establishment. Competent Authority : The Local Concerned Authority in each Emirate of the State. Biodiversity : The variability among living organisms of all sources, including terrestrial and marine ecosystems, aquatic organisms, and ecological complexes that are a part thereof, including diversity among species, and between species and ecosystems. Genetic Resources : Any material of plant, animal, microbial or other origin containing functional units of heredity of actual or potential value. Biosafety : Measures followed for ensuring the safe use of modern biotechnology applications for both humans and environment, with a view to mitigating or eliminating the potential risks arising therefrom. Living Organism : Any biological entity capable of transferring or replicating genetic material, including sterile organisms, viruses, viroids, animals, plants, and microorganisms. Genetic Modification : Modifying genetic material by using modern biotechnology. Genetically Modified Organism (GMO) : A living organism that possesses a novel combination of genetic material, differing from its original genetic composition, obtained through the use of modern biotechnology.
-- 3 of 13 --
Federal Law of 2020 Regarding the Biosafety of Genetically Modified Organisms (GMOs) and Their Products 4 GMO Products : Products formulated from or containing GMO, derivatives or residues thereof, or other products that include or are composed of a percentage of Genetically Modified Component. Genetically Modified Component : Any part containing the genetically modified code. Modern Biotechnology : In vitro nucleic acid techniques, including recombinant deoxyribonucleic acid (DNA) and direct injection of nucleic acid into cells or organelles, or the fusion of cells beyond the taxonomic family, that overcome natural physiological reproductive or recombination barriers and that are not techniques used in traditional breeding and selection. Contained Use : The activity that takes place within a facility, and that involves GMOs subject to specific measures that effectively prevent their contact with the external environment and their impact on such environment. Release : The introduction of GMOs or Products thereof into the environment. Circulation : Sale or offer for sale, storage or possession, whether permanently or temporarily. Facility : The facility, installation or any other premises, whether fixed or mobile, permanent or temporary, authorized to manufacture, produce, develop or circulate GMOs or Products thereof. Risks : Possibility of causing adverse effects as a result of exposure to the source of risk resulting from GMOs or Products thereof. Risk Assessment : The evaluation of the potential adverse effects of GMOs or Products thereof on the conservation and sustainable use of biological diversity and on the health and safety of humans and environment. Response Measures : Measures taken to prevent, minimize, control or mitigate damage.
-- 4 of 13 --
Federal Law of 2020 Regarding the Biosafety of Genetically Modified Organisms (GMOs) and Their Products 5
